相关实验视频

Updated: Jul 19, 2026

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C

Published on: March 25, 2016

在母体免疫激活中改善后代行为的潜在策略:阿曼塔丁介导的神经炎症的抑制

Jianfei Wu¹, Yu Liu¹, Binglong Wang¹

¹Zigong Institute of Brain Science, Zigong Psychiatric Research Center, Zigong Affiliated Hospital of Southwest Medical University, Zigong, China.

Animal models and experimental medicine

|July 23, 2025

概括

阿曼塔丁 (AMA) 预防暴露于母体免疫激活 (MIA) 的后代的神经发育障碍. 这种抗病毒药物减少神经炎症和神经元损伤,为MIA相关疾病提供潜在的治疗方法.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

怀孕期间母亲免疫激活 (MIA) 会增加后代患神经发育障碍的风险.
阿曼塔丁 (AMA) 是一种抗病毒药物,用于神经疾病,但其在MIA中的有效性尚未证明.

研究的目的:

调查阿曼塔丁 (AMA) 在减轻母体免疫激活 (MIA) 对后代神经发育的影响方面的疗效.
探索AMA作为预防MIA诱导的神经精神疾病的治疗剂的潜力.

主要方法:

在小鼠模型中,MIA被诱导使用聚氨酸-聚乙烯酸 (poly(I:C)) 在关键发育时期给予AMA.
进行了行为测试,神经元形态评估,亡测定和分子分析 (细胞因子水平,蛋白质和基因表达).
使用BV-2细胞进行了体外研究,以检查AMA对炎症的直接影响.

主要成果:

艾玛治疗显著降低了母体血液和后代的插白素-6 (IL-6) 水平.
在MIA后代中,AMA的使用改善了类似自闭症的行为,并预防了神经元损伤和神经炎症.
在体外,AMA降低了促炎性细胞因子 (IL-6,TNF-α,IL-1β) 的调节,并调节了微质激活通路.

结论:

阿曼塔丁 (AMA) 在患有MIA的母亲的后代中显示出对神经精神疾病的预防作用.
AMA的治疗潜力在于其减轻神经元损伤,减少细胞亡和抑制神经炎症的能力.
抗病毒药物AMA显示出作为对孕产妇免疫激活 (MIA) 的潜在治疗方法的希望.

关键词:

阿曼塔丁 (Amantadine) 是一种阿曼塔丁 (Amantadine) 的一种药物.灭症 (apoptosis) 是一种死亡的过程.自闭症自闭症是什么干白素-6 (IL-6) 是一种干白素.孕产妇的免疫激活神经炎症是一种神经炎症.

更多相关视频

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.